Erythromycin Pledgets
If you find any inaccurate information, please let us know by providing your feedback here
This article is compiled based on the United States Pharmacopeia (USP) – 2025 Edition
Issued and maintained by the United States Pharmacopeial Convention (USP)
Erythromycin Pledgets are suitable absorbent pads impregnated with Erythromycin Topical Solution. Pledgets contain not less than 90.0 percent of the labeled volume of Erythromycin Topical Solution.
Packaging and storage-Preserve in tight containers.
Labeling-Label Pledgets to indicate that each Pledget is to be used once and then discarded. Label Pledgets also to indicate the volume, in mL, of Erythromycin Topical Solution contained in each Pledget, and the concentration, in mg of erythromycin per mL, of the Erythromycin Topical Solution.
USP REFERENCE STANDARDS (11)-
USP Erythromycin RS
Identification-Prepare a test solution by shaking one Pledget with methanol, and diluting appropriately to obtain a concentration of about 2.5 mg of erythromycin per mL. Prepare a Standard solution of USP Erythromycin RS in methanol containing 2.5 mg per mL. Apply separately 10 µL of each solution to a thin-layer chromatographic plate (see Chromatography (621)) coated with a 0.25-mm layer of chromatographic silica gel. Place the plate in an unlined chromatographic chamber, and develop the chromatogram in a solvent system consisting of a mixture of methanol and chloroform (85:15) until the solvent front has moved about 7 cm. Remove the plate from the chamber, mark the solvent front, and allow the solvent to evaporate. Spray the plate with a mixture of alcohol, p-methoxybenzaldehyde, and sulfuric acid (90:5:5). Heat the plate at 100° for 10 minutes, and examine the chromatogram, in which erythromycin appears as a black-to-purple spot: the R, value of the principal spot obtained from the test solution corresponds to that obtained from the Standard solution.
Other requirements-The Erythromycin Topical Solution expressed from Pledgets meets the requirements for Water and Alcohol content under Erythromycin Topical Solution.
Topical solution assay-Proceed as directed for erythromycin under Antibiotics-Microbial Assays (81), using the solution expressed from not less than 10 Pledgets. Dilute an accurately measured volume of this solution quantitatively with Buffer B.3 to obtain a Test Dilution having a concentration assumed to be equal to the median dose level of the Standard.
Assay and minimum volume-Proceed as directed for erythromycin under Antibiotics-Microbial Assays (81), assaying 10 Pledgets individually.
Transfer 1 Pledget to a suitable container, add about 50 mL of Buffer B.3, and shake for 2 minutes. Transfer the solution so obtained to a 100-mL volumetric flask. Wash the Pledget with two 20-ml portions of Buffer B.3, add the washings to the 100-mL volumetric flask, dilute with Buffer B.3 to volume, and mix. Dilute an accurately measured volume of this solution quantitatively with Buffer B.3 to obtain a Test Dilution having a concentration assumed to be equal to the median dose level of the Standard. Calculate the volume, in mL, of Erythromycin Topical Solution in each Pledget taken by dividing the number of mg of erythromycin in each individual Pledget by the number of mg of erythromycin in each mL of Erythromycin Topical Solution as obtained in the Topical Solution assay. The volume of Erythromycin Topical Solution in each Pledget is not less than 90.0% of the labeled amount. If this requirement is not met, determine the volume of Erythromycin Topical Solution in each of 20 additional Pledgets. The volume of Erythromycin Topical Solution in not more than 1 of the 30 Pledgets is less than 90.0% of the labeled amount.
